Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour

Intensive Care Medicine
T FlossdorfH B Hopf

Abstract

We report a patient with massive pulmonary embolism and circulatory shock during pregnancy (31st gestational week) and preterm labour who has been successfully treated with recombinant tissue type plasminogen activator. Thrombolysis was performed using 10 mg.h-1 over 4 h followed by 2 mg.h-1 for 1 h 30 min resulting in complete resolution of cardio-respiratory symptoms. Except for slight bleeding from one puncture site no complications occurred. At 48 h after the end of thrombolytic therapy the patient was delivered spontaneously of a male preterm healthy infant. The relevance of this new thrombolytic agent in the treatment of massive life-threatening pulmonary embolism during pregnancy is discussed.

References

Jan 1, 1977·The Medical Journal of Australia·D R McTaggart, T G Ingram
Oct 6, 1988·The New England Journal of Medicine·J Loscalzo, E Braunwald
Aug 1, 1986·American Journal of Obstetrics and Gynecology·G L Delclos, F Davila
Dec 1, 1983·Clinical Obstetrics and Gynecology·J C Bolan

❮ Previous
Next ❯

Citations

Aug 1, 1996·Catheterization and Cardiovascular Diagnosis·F M Eickman
Nov 18, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D K WoodwardK A Granger
Jul 1, 1997·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M FleyfelF Puech
May 10, 2006·Journal of Thrombosis and Thrombolysis·Georg LeonhardtEkkehard Schleussner
Oct 1, 1995·Obstetrics and Gynecology·W B KramerK J Moise
Jul 1, 1995·Obstetrical & Gynecological Survey·M A TurrentineM M Ramirez
Aug 19, 2004·Cardiology in Review·Shadi A QasqasUri Elkayam
Jul 21, 2012·Cardiology Clinics·William H FrishmanWilbert S Aronow
Nov 6, 2007·American Journal of Obstetrics and Gynecology·Adam J DuhlUNKNOWN Pregnancy and Thrombosis Working Group
Jun 23, 2005·American Journal of Obstetrics and Gynecology·Jonathan Y Song, Leonard Valentino
Sep 1, 2013·Obstetric Medicine·Eric J Gartman
Sep 12, 2017·Pharmacotherapy·Mojdeh S HeavnerRachel F Eyler
Jan 31, 2018·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Marina Sousa GomesNuno Montenegro
Aug 28, 2013·Neurologia Medico-chirurgica·Teruyuki Hirano
Apr 11, 2015·The Annals of Pharmacotherapy·Kimberly BrandtJeffrey Quedado
Apr 30, 2020·Journal of Thrombosis and Thrombolysis·David RodriguezFrancisco Nevarez
May 29, 2018·Vascular and Endovascular Surgery·Vy T HoSapan S Desai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.